Dr. Bruce Doll

Assistant Vice President for Technology Research and Innovation

Uniformed Services University

Dr. Bruce Doll is the Assistant Vice President for Technological Research and Innovation, Office of Research, Science Director (Armed Forces Radiobiological Research Institute – AFRRI) and Deputy Director (Precision Medicine Research Center for Military Medical Education and Research - PRIMER) for at the Uniformed Services University (USU) in Bethesda, Maryland. He leads the development and integration of database and biobanking management within the research portfolio, Laboratory Animal Management and the advancement of novel technologies focused upon military medical requirements. His formal education includes a DDS from SUNY Buffalo, Periodontics specialty certificate from Navy Postgraduate Dental School, PhD from Penn State in cell and molecular biology, and MBA in acquisition from the Navy Postgraduate School. His post-doctoral work focused on the delivery of regenerative induce bone formation in areas where it had been lost due to trauma, genetics and disease. He has qualified as a LSS Black Belt. During 34 years of service with the US Navy, he served in medical/dental leadership positions supporting NATO, US Navy and US Marine Corps, INCONUS, underway and OCONUS. Several times deployed, RADM (ret) Doll completed his service as both the first Director of Research, Development and Acquisition Directorate for the DHA in Falls Church, VA and the Deputy Commander, US Army Medical Research and Material Command, Fort Detrick, Maryland overseeing execution of the $1.4B Defense Health Program funded medical research. He has held numerous academic appointments with Carnegie Mellon University, University of Pittsburgh, Oregon Health Sciences University, University of Maryland, Pennsylvania State University and Rutgers University prior to coming to USU. He served as the Chief Operating Officer for the Rutgers – Cleveland Clinic Consortium for the Armed Forces Institute of Regenerative Medicine I. He has served on several scientific boards, published in the area of bone regeneration, contributed to patents for bone regeneration and is a former grantee of the NIH and NIST.